
Chloroquine
The National Agency for Food and Drug Administration and Control ( NAFDAC ) has approved the production of chloroquine for clinical trials in the search for a cure for COVID19.
Mojisola Adeyeye, the Director-General of the agency, made the announcement on Friday.
The DG said that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.
“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.
Therefore the medicine is being approved just for the clinical trials,” Adeyeye said.
She, therefore, called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets.
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of the clinical trial,” Adeyeye added.
You may be interested

Tears As Anambra Govt Resumes Demolition in Awka, Days After Election
Webby - March 23, 2023Advertisement By Izunna Okafor, Awka Some residents and shop owners in Awka, Anambra State capital, were thrown into wailing and…

Ramadan: Let’s imbibe lessons in piety, tolerance, speaker Obasa tells Muslims
Webby - March 23, 2023The Speaker of the Lagos State House of Assembly, Rt. Hon. Mudashiru Obasa, has said that the 30-day Islamic fasting…

Keyamo petitions DSS, demands Peter Obi and Baba-Ahmed’s arrest for allegedly inciting insurrection
Webby - March 23, 2023Minister of State, Labour and Employment, Mr Festus Keyamo (SAN), has called for the arrest and pros£cution of Labour Party’s…